Hydroxycut Recall Eyed As Trigger For Closer Look At Supplement AERs
This article was originally published in The Tan Sheet
Executive Summary
The dietary supplement industry looks to FDA's Hydroxycut investigation for a sign on whether the agency will analyze adverse event reports more closely following a high-profile product recall